Details for New Drug Application (NDA): 022219
✉ Email this page to a colleague
The generic ingredient in AVEED is testosterone undecanoate. There are sixty-nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the testosterone undecanoate profile page.
Summary for 022219
Tradename: | AVEED |
Applicant: | Endo Operations |
Ingredient: | testosterone undecanoate |
Patents: | 2 |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 022219
Generic Entry Date for 022219*:
Constraining patent/regulatory exclusivity:
Dosage:
INJECTABLE;INTRAMUSCULAR |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for NDA: 022219
Mechanism of Action | Androgen Receptor Agonists |
Suppliers and Packaging for NDA: 022219
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AVEED | testosterone undecanoate | INJECTABLE;INTRAMUSCULAR | 022219 | NDA | ENDO USA, Inc. | 67979-511 | 67979-511-43 | 1 VIAL, SINGLE-USE in 1 CARTON (67979-511-43) / 3 mL in 1 VIAL, SINGLE-USE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INTRAMUSCULAR | Strength | 750MG/3ML (250MG/ML) | ||||
Approval Date: | Mar 5, 2014 | TE: | RLD: | Yes | |||||
Patent: | 7,718,640 | Patent Expiration: | Mar 14, 2027 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | 8,338,395 | Patent Expiration: | May 8, 2027 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | TESTOSTERONE REPLACEMENT THERAPY IN ADULT MALES FOR CONDITIONS ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE; PRIMARY HYPOGONADISM (CONGENITAL OR ACQUIRED); HYPOGONADOTROPIC HYPOGONADISM (CONGENITAL OR ACQUIRED). |
Complete Access Available with Subscription